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Brugian filariasis (caused by the nematodes Brugia malayi and B. timori) is an important cause of disability
in Southeast Asia. Improved diagnostic tests are needed for filariasis elimination programs (to identify areas
of endemicity and to monitor progress) and for diagnosis of the disease in infected individuals. We have
developed and evaluated two real-time PCR assays for detecting Brugia DNA in human blood and compared
the results of these assays to those of “gold standard” assays. One assay uses a TaqMan probe (TaqM) to
amplifiy a 320-bp “HhaI repeat” DNA sequence. The other assay uses a minor groove binding probe (MGB)
and modified nucleotides in primers (Eclipse MGB) to amplify a 120-bp fragment of the HhaI repeat. This
assay detects 22 copies of the target sequence, and it is more sensitive than the TaqM assay. Both assays were
evaluated with human blood samples from two different areas of endemicity. The MGB assay was as sensitive
as membrane filtration and microscopy for the detection of B. malayi infection in 57 blood samples recovered
at night from patients in Sulawesi, Indonesia. The MGB assay also detected parasite DNA in 17 of 31 (55%)
of microfilaria-negative day blood samples from these subjects. This test was more sensitive than the conven-
tional and the TaqM PCRs (and was almost as sensitive as night blood membrane filtration) for the detection
of infection in 52 blood samples recovered at night from individuals in an area of B. timori endemicity on Alor
Island, Indonesia, where microfilaria-positive individuals had low densities after mass treatment. Thus, the
Eclipse MGB real-time PCR assay is a sensitive means of detecting Brugia parasite DNA in human blood.
PCR-based assays have become the preferred methods for
the diagnosis of many parasitic infections in diagnostic refer-
ence laboratories for several reasons. First, these assays do not
require extensive training, experience, or skills in microscopy.
Second, the equipment and practical skills required to perform
PCR are now widespread and are also increasingly widespread
in the developing world. In recent years, real-time PCR has
increasingly replaced conventional PCR (C-PCR) for technical
reasons (improved sensitivity) and practical reasons (faster
results with less labor). In addition, real-time PCR assays have
the potential to be used as high-throughput diagnostic tools for
the screening of blood donors, for epidemiological studies, or
for the monitoring of control programs.
Brugian filariasis is a mosquito-borne illness that is caused
by the parasitic nematodes Brugia malayi and Brugia timori;
approximately 13 million people are infected, mainly in India
and Southeast Asia. In 2000, the Global Program to Eliminate
Lymphatic Filariasis was implemented with the primary goal of
interrupting filariasis transmission by using mass drug admin-
istration (MDA) with microfilaricidal drugs (9, 21, 30). Im-
proved methods for the diagnosis of filariasis are urgently
needed to monitor the impact of MDA on infection rates and
to detect a resurgence of infection after MDA is discontinued.
The traditional method for the diagnosis of brugian filariasis
is the detection of microfilariae (mf) in blood samples recov-
ered at night (night blood samples) by microscopy with a thick
smear, the modified Knott’s test, or membrane filtration. The
disadvantages of mf detection by microscopy are low sensitivity
when small amounts of blood are examined, the high costs of
membrane filters, the need for specially trained microscopists,
and the cumbersome assessment of individual slides. A rapid-
format antigen detection test (Filariasis Now; Binax, Inc., Port-
land, ME) is available for the detection of infections with the
closely related filarial parasite Wuchereria bancrofti, and this
test is widely used for mapping and monitoring the impact of
mass treatment programs (28). However, the card test does not
detect Brugia infections. Several recombinant B. malayi anti-
gens have been used in enzyme-linked immunosorbent assays
(ELISAs) or rapid-format assays to detect filaria-specific im-
munoglobulin G4 antibodies (17). A disadvantage of antibody
detection is that it is an indirect diagnostic approach which
relies on the host’s immune response; positive antibody test
results do not necessarily indicate current infection.
Several C-PCR assays have been developed for the molec-
ular diagnosis of filarial infections. These assays detect re-
peated parasite DNA sequences in human blood and mosquito
vectors (18, 33). These methods detect DNA of W. bancrofti or
B. malayi and B. timori in blood samples or in mosquitoes with
high sensitivities and specificities (2, 4–6, 8, 10, 14, 22, 29).
However, they require cumbersome methods for the detection
of PCR products by agarose gel electrophoresis, Southern blot-
ting, or ELISA or with expensive DNA detection test strips.
C-PCR assays based on gel electrophoresis have subjective
endpoints and they are difficult to standardize; they are also
prone to contamination because they require the manipulation
of PCR products.
Real-time PCR is a powerful and relatively new tool for
high-throughput detection of parasite DNA and is increasingly
replacing C-PCR and microscopy for the diagnosis of several
parasitic infections (1, 19, 25). Real-time PCR has been used in
* Corresponding author. Mailing address: Department of Internal
Medicine, Infectious Diseases Division, Washington University School
of Medicine, 660 South Euclid Avenue, Campus Box 8051, St. Louis,
MO 63110. Phone: (314) 454-7876. Fax: (314) 454-5293. E-mail:
Pufische@im.wustl.edu.
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filariasis research for gene expression studies and to quantify
Wolbachia endobacteria, but it has not been used extensively
for the molecular diagnosis of filarial infections (11, 12, 15).
The purpose of the present study was to develop real-time
PCR assays for the detection of Brugia DNA and to compare
the performance of these assays with those of C-PCR and with
blood filtration as the “gold standard” for the parasitological
detection of B. malayi. We have developed two assay formats
and evaluated these with parasite DNA samples and human
blood samples from areas in Indonesia where filariasis is en-
demic. Our results show that real-time PCR is superior to
C-PCR for the detection of Brugia DNA in human blood
samples.
MATERIALS AND METHODS
Parasite DNA and HhaI plasmid. Adult B. malayi worms were obtained from
experimentally infected jirds (Mongolian gerbils [Meriones unguiculatus]). The
worms were washed three times with RPMI 1640 medium and frozen in phos-
phate-buffered saline at 70°C until use. Adult Brugia pahangi worms were
generously provided by T. R. Klei (School of Veterinary Medicine, Louisiana
State University). W. bancrofti microfilariae were isolated from human blood by
membrane filtration.
A control plasmid was constructed by cloning a PCR product of the B. malayi
HhaI repeat (20) into the pCR4-TOPO vector (Invitrogen, Carlsbad, CA), ac-
cording to the manufacturer’s instructions. The plasmid was propagated in Esch-
erichia coli and purified by using a QIAprep spin miniprep kit (QIAGEN,
Valencia, CA). The identity of the cloned HhaI repeat was confirmed by DNA
sequencing. The size of the plasmid was 4,281 bp (including the 320-bp HhaI
sequence). One microgram of the plasmid contains approximately 3.6 fmol plas-
mid DNA; 1 fg of plasmid DNA contains 216 copies of the HhaI sequence. The
concentration of the plasmid was measured with a GeneQuant instrument (Phar-
macia Biotech, Cambridge, United Kingdom).
Human blood samples. Blood samples from individuals living in areas highly
endemic for B. malayi or B. timori were collected during field surveys in eastern
Indonesia in 1998, 2003, and 2004 (5, 27). Venous nighttime blood samples were
collected between 7 p.m. and 11 p.m. in EDTA-coated vacuum tubes in central
Sulawesi (B. malayi) and on Alor Island (B. timori). In addition, in the area where
B. malayi is endemic, blood samples were collected during the day (day blood
samples), between 9 a.m and noon, from some of the microfilaremic individuals
who had provided night blood samples. Blood donors on Sulawesi were un-
treated. Most blood donors on Alor Island had been treated with two to three
rounds of diethylcarbamazine combined with albendazole. Blood samples from
Alor Island were collected 10 months after the last round of MDA; and mf
densities were relatively low, with a few exceptions for individuals who had not
participated in MDA. Microfilaria densities were assessed by filtration of 1 ml
night blood, as described previously (27). Blood samples from Sulawesi were kept
at ambient temperatures in the field for 1 to 2 days and were then transported to
a central laboratory and stored at 20°C until use in DNA studies. The B. timori
samples from Alor Island were preserved in the field by adding 500 mM EDTA
up to a final concentration of 100 mM; these samples were stored for up to 3
months at ambient temperatures, and they were later stored at 20°C. Use of a
high concentration of EDTA inhibits DNases and enables storage at ambient
temperatures. However, EDTA can inhibit the PCR if it is not totally removed
during DNA extraction.
The project was approved by the ethical review board of the University of
Indonesia in Jakarta. Informed consent was obtained from all individuals who
participated in the study. Blood samples from 3 patients infected with W. ban-
crofti, 3 patients infected with Onchocerca volvulus, 18 individuals from tropical
Africa (where is Brugia not endemic) without clinical signs of disease, and 6
healthy Europeans available from previous studies were used as controls.
DNA extraction. Total genomic DNA was extracted from adult worms by using
a QIAamp DNA extraction kit (QIAGEN) and eluted in 200 l of sterile water.
Total DNA from thawed blood samples was prepared by using the QIAamp
blood DNA extraction kit (QIAGEN). DNA was extracted from 100 l of night
blood or from 200 l of day blood. For each DNA extraction, at least three
negative control blood samples (human blood) and one microfilaria-positive
sample (human or jird blood) were included. In order to detect potential PCR
inhibitors in the DNA extracts, PCR-negative samples were spot-checked by
adding Brugia DNA and were retested by C-PCR or real-time PCR, but no
significant inhibition was detected. DNA samples were kept frozen at 20°C
until use. The technicians who performed the DNA extractions and subsequent
real-time PCR testing did not know the infection status of the blood samples
being tested.
Design of real-time PCR assays. The HhaI repeat (GenBank accession nos.
M12691 and AF499109 to AF499129) was used as the target sequence for several
reasons. This sequence is arranged as a tandem repeat and is present at several
thousand copies per haploid genome (7). Furthermore, most C-PCR assays for
Brugia have used this target, and no consistent sequence variation has been
reported in various strains of B. malayi and B. timori (3, 6). The HhaI repeat is
AT rich, and closely related sequences are present in zoonotic filarial species
such as Brugia pahangi; this makes it difficult to design primers and probes
specific for the Brugia species that are parasitic in humans (B. malayi and B.
timori). In addition, even within one parasite, the numbers of copies of the HhaI
repeat are not identical, and there are conserved and more variable areas.
Conserved regions rarely span more than 30 bp, and selection of long primers
and probes can decrease detection sensitivity. Primer Express software for
TaqMan (TaqM) assays (Applied Biosystems, Foster City, CA) recommended
the use of primers and a probe that were 28 to 40 bp long. Therefore, we decided
to use the published primers and probe sequences for the conventional PCR in
a TaqM assay (5, 18).
The use of modified nucleotides (“supernucleotides”) together with minor
groove binding probe (MGB) probes increases the melting temperatures of
oligonucleotides to complementary sequences. This enables the design of short
and specific primers and probes for AT-rich target sequences. Therefore, an
MGB Eclipse assay was designed by using specific software (Nanogen, Bothell,
WA) to amplify a 118-bp fragment of the HhaI repeat (Table 1).
TaqM real-time PCR. The primers and probe were synthesized by Integrated
DNA Technologies Inc., Coralville, IA (for sequence and labeling information,
see Table 1). The primers were purified by the supplier by standard desalting,
while the labeled probes were purified by dual high-pressure liquid chromatog-
raphy. Real-time PCR mixtures included 12.5 l of Universal TaqMan master
mixture (Applied Biosystems), 400 nM each primer, and 125 nM probe in a final
volume of 25 l. This master mixture contained dUTP and uracil N-glycosylase
TABLE 1. Nucleotide sequences of the oligonucleotide primers and probes used to amplify the HhaI repeat by either
TaqM assay or Eclipse MGB assay
Name (position)a Sequence (5-3)b Reporter Quencher Passive reference Data collection
T-HhaI-For (1) GCGCATAAATTCATCAGC
T-HhaI-Rev (301) GCGCAAAACTTAATTACAAAAGC
T-HhaI-probe (238) ACGTGAATTGTACCAGTGCTGGTCG FAMc (5) TAMRAd (3) ROXe Extension
MGB-HhaI-For (253) GCAATATACGACCAGCAC
MGB-HhaI-Rev (139) ACA*TTAGA*CAAGGAAATTGGTT
MGB-HhaI-probe (192) TTTTTAGTAGTTTTGGC FAM (3) Eclipse dark (5) None Annealing
a T-HhaI, TaqM assay; MGB-HhaI, Eclipse MGB assay. The nucleotide position refers to the HhaI sequence in GenBank with accession number M12669.
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(UNG) to prevent contamination with previously amplified PCR products. One
microliter of template was added to 24 l PCR master mixture in 96-well
MicroAmp optical plates (Applied Biosystems). Thermal cycling and data anal-
ysis were done with an ABI Prism 7000 or 7300 instrument (Applied Biosystems).
Cycling conditions included 2 min of incubation at 50°C for UNG performance,
10 min at 95°C for activation of Taq polymerase and deactivation of UNG, and
40 cycles of 10 s of denaturation at 95°C and 60 s at 60°C for combined annealing
and extension. A three-step protocol with 10 s of denaturation at 95°C, 30 s of
annealing at 55°C, and 30 s of extension at 72°C was evaluated; but that protocol
was no more sensitive than the two-step protocol. All PCRs were carried out in
duplicate. The cycle threshold (Ct) value was defined as the number of PCR
cycles required for the fluorescence signal of the amplified products to exceed
the detection threshold value. The Ct values reported for the samples are the
arithmetic means for both duplicates. Preliminary studies showed that the assay-
to-assay and person-to-person variations for identical samples were 1 cycle.
Therefore, samples were retested if only one of the duplicates produced a
positive signal or if the Ct value was borderline (39 cycles). Water was used as a
no-template negative control and 100 pg of B. malayi DNA served as a positive
control in all real-time PCR runs.
Eclipse MGB real-time PCR. The primers and probe were purchased from
Nanogen and were delivered as 20 concentrates. The reaction mixture for the
real-time PCR consisted of 12.5 l of Eclipse MGB PCR reagent buffer con-
taining 1.25 U Jumpstart Taq DNA polymerase (Sigma-Aldrich, St. Louis, MO),
1.25 l primer mixture, 1.25 l probe, 0.5 U UNG (Applied Biosystems), and
water up to a final volume of 25 l. Cycling conditions included a 20-min
incubation at 37°C for UNG performance; 2 min at 95°C for activation of Taq
polymerase and deactivation of UNG; and 40 cycles of 10 s at 95°C for dena-
turation, 30 s at 58°C for annealing, and 30 s at 76°C for extension. Data
collection was performed at the annealing step (Table 1). When the ABI 7000
instrument was used, the cycling was programmed to start with the extension
step, followed by denaturation and annealing, because this instrument automat-
ically collects fluorescence data in the last step of each cycle.
C-PCR. C-PCR was performed with all night blood samples. The HhaI repeat
was amplified by using the primers and reaction conditions described previously
(6, 18). Following PCR, 10 l of the PCR product was electrophoresed on a 1.5%
agarose gel containing ethidium bromide. Gels containing DNA bands were
viewed with a UV light box and photographed. Samples showing DNA bands at
the expected size of 320 bp were scored as C-PCR positive.
Data analysis. Target sequence copy numbers were calculated from the Ct
values by using the external standard curves generated with the TaqM or Eclipse
MGB assays (16). The association between mf counts and Ct values or copy
numbers was analyzed by the Spearman rank test.
RESULTS
Sensitivity of TaqM real-time PCR. Serial dilutions (1 ng to
0.1 fg) of genomic B. malayi DNA extracted from adult female
worms were tested to assess the sensitivity of the TaqM real-
time PCR. The limit for reliable detection of the HhaI repeat
in genomic DNA was about 100 fg of total DNA (Fig. 1). No
fluorescence signal was obtained when purified DNA from W.
bancrofti, B. pahangi, or humans was tested; this confirmed the
specificity of the assay.
For better standardization, the assay was also evaluated by
using a plasmid containing the HhaI target sequence. The
detection limit obtained with the plasmid was similar to that
observed with genomic DNA, and no significant difference in
Ct values was observed over the range of 1 ng to 100 fg (P 
0.145) (Fig. 1). We estimate that the TaqM real-time PCR
assay has a detection limit of approximately 22,000 copies of
the HhaI target. Quality control testing revealed that this assay
had a mean efficiency of 101.5%  3.5% (cutoff of efficiency,
93 to 105%).
Sensitivity of Eclipse MGB real-time PCR. Serial dilutions
of genomic B. malayi DNA and plasmid DNA containing the
HhaI target sequences were tested. The detection limit for
genomic DNA was approximately 0.1 fg. This corresponds to
22 copies of the HhaI sequence in the plasmid DNA. Over the
range from 1 ng to 0.1 fg, the Ct values for the plasmid were
about 2 cycles lower than those for genomic DNA. This means
that genomic DNA contains only about 25% of the number of
copies of the target sequence in an equivalent amount of plas-
mid DNA (Fig. 1). Since 7.6% of the plasmid is the target
sequence, it can be estimated that the target sequence detected
in this assay accounts for approximately 1.9% of total genomic
B. malayi DNA. Quality control testing showed that the assay
had an average amplification efficiency of 98.5%  4.5% (cut-
off of efficiency, 93 to 105%).
The MGB assay did not detect a signal with W. bancrofti, B.
pahangi, or human DNA. Interestingly, the primers used in the
TaqM assay amplify a HhaI target in B. pahangi (visible by
agarose gel electrophoresis), but the TaqMan probe does not
bind to this target. In contrast, the primers used in the Eclipse
MGB assay do not amplify any target in B. pahangi DNA (data
not shown).
Real-time PCR to detect Brugia malayi or B. timori DNA in
night blood samples. The operational sensitivity of the PCR
assay may differ from the sensitivity assessed by using purified
target DNA or plasmid DNA containing the target sequence.
Therefore, the sensitivities of the TaqM assay and the MGB
assay were evaluated with blood samples from humans living in
areas highly endemic for brugian filariasis. These results were
compared to those obtained by C-PCR with the same samples.
(i) B. malayi samples from Sulawesi. We tested night blood
samples from 36 microfilaremic and 21 microfilaria-negative
individuals who lived in an area in central Sulawesi, Indonesia,
where nocturnally periodic B. malayi is endemic. The geomet-
ric mean microfilaria density in 1 ml of positive blood samples
was 63 mf/ml (range, 1 to 1,812 mf/ml). The PCR assays tested
FIG. 1. Sensitivities of the TaqM assay (gray lines) and Eclipse
MGB (black lines) real-time PCR for detection of genomic Brugia
malayi DNA (stars) or plasmid DNA (circles) containing the HhaI
sequence. The amount of DNA (ng; x axis) is plotted against the cycle
threshold values (y axis). Strong inverse correlations were observed
between the amount of DNA and Ct values (both tests and both DNA
samples; R values ranged from 0.9899 to 0.9964; P  0.001).
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1 l of DNA template (1% of the DNA isolated from 100-l
blood samples per reaction mixture). The MGB assay was
positive for all 36 samples, while both the TaqM and the
C-PCR assays were positive for 33 samples (Table 2). The
MGB and the C-PCR assays detected Brugia DNA in 2 of 21
samples of individuals who tested microfilaria negative by fil-
tration, while the TaqM assay was positive for 1 of these sam-
ples. There was no significant difference in sensitivity between
the three PCR assays (P	 0.05). These results show that in this
area with moderate to high mf densities, the three PCR assays
had sensitivities similar to the sensitivity of membrane filtra-
tion, although they sample a smaller quantity of blood.
(ii) B. timori samples from Alor Island post-MDA. The sec-
ond set of samples was obtained from 31 microfilaremic and 21
microfilaria-negative individuals from an area on Alor Island,
Indonesia, where B. timori is endemic. In contrast to the B.
malayi samples, the B. timori samples were collected 10 months
after two rounds of MDA of diethylcarbamazine with albenda-
zole; subjects with persistent microfilaremia in this area gen-
erally had very low microfilaria densities (Table 2). The geo-
metric mean microfilarial density in microfilaremic individuals
was 13 mf/ml. C-PCR detected Brugia DNA in 22 of the 31
microfilaria-positive samples, the TaqM assay detected Brugia
DNA in 17 samples, and the Eclipse MGB assay detected
Brugia DNA in 26 samples. Among the 21 samples from mi-
crofilaria-negative individuals, 3 were positive by the TaqM
assay and 7 were positive by the MGB assay. One of these
real-time PCR-positive and filtration-negative samples was ob-
tained from a person with filarial lymphoedema, while two
other samples were collected from individuals who had tested
microfilaria positive 1 year earlier.
(iii) Other filarial infections and control samples from ar-
eas of nonendemicity. All samples from individuals infected
with other filarial parasites, such as W. bancrofti (n  3) or O.
volvulus (n  3), or from Africans (n  18) or Europeans (n 
6) with no history of exposure to Brugia were negative by all
three PCR assays, confirming the high specificities of the as-
says. No higher background was observed with these samples
than with the negative no-template controls.
Real-time PCR to detect DNA of nocturnally periodic B.
malayi in day blood. We examined day blood samples from 31
individuals from Sulawesi who had B. malayi microfilaremia in
their night blood, as determined with the Eclipse MGB assay,
because this was the most sensitive of the three PCR assays
tested. All of these samples were mf negative by microscopy.
The MGB assay detected Brugia DNA in 17 of 31 samples
(55%) (Table 3). The day blood samples that were negative by
the MGB assay had a geometric mean mf density in night
blood of 20 per ml, while the mf density in the night blood of
people whose day blood was positive by the MGB assay was
136 per ml. This difference was statistically significant (P 	
0.01). All six samples with 264 or more mf per ml night blood
but with no mf in the day blood were MGB positive. These
results indicate that the MGB assay often detected filarial
DNA in day blood when no mf were detected by microscopy.
Relation between HhaI copy numbers and parasite load. (i)
Night blood samples. We used an external standard curve to
estimate the HhaI copy numbers in blood samples based on the
Ct values obtained by the TaqM assay or the Eclipse MGB
real-time PCR. The estimated copy numbers were positively
correlated with the mf densities for both assays (Fig. 2). The
correlation was significant only for the B. malayi night blood
samples from Sulawesi, which had a broader range of mf
counts (TaqM assay R value, 0.767; Eclipse MGB assay R
value, 0.42; P  0.05). These results indicate that real-time
PCR assays can provide information on mf densities without
the need for plate-specific standard curves and internal control
samples.
(ii) Day blood samples from Sulawesi. The geometric mean
copy number in the day blood samples was estimated to be
5.5 104 copies/l (range, 1,400 to 1.7 107 copies/l). For
comparison, the corresponding night blood samples had a
geometric mean copy number of 13  104 copies/l (range,
530 to 1.4  107 copies/l). Although the day blood samples
had significantly lower copy numbers than the night blood
TABLE 2. Conventional and real-time PCR detection of HhaI repeat DNA in blood from Indonesian subjects living in areas
highly endemic for Brugia malayi or Brugia timori
No. of mf/mla
Brugia malayi Brugia timori
No. of
samples
No. (%) of samples positive by b:
No. of
samples
No. (%) of samples positive by:
C-PCR TaqM assay Eclipse MGBassay C-PCR TaqM assay
Eclipse MGB
assay
0 21 2 (10) 1 (5) 2 (10) 21 0 (0) 3 (14) 7 (33)
1–10 4 2 (50) 4 (100) 4 (100) 15 9 (60) 5 (33) 10 (67)
11–50 12 11 (92) 10 (83) 12 (100) 8 6 (75) 3 (38) 8 (100)
	50 20 20 (100) 19 (95) 20 (100) 8 7 (88) 7 (88) 8 (100)
a The mf density was estimated by membrane filtration of 1 ml of venous blood collected at night.
b PCR was performed with DNA extracted from 100-l night blood samples. B. malayi samples were from untreated subjects in Sulawesi with blood frozen shortly
after collection. B. timori samples from Alor Island were mostly from previously treated subjects; blood was preserved in the field in EDTA and later frozen.
TABLE 3. Sensitivity of Eclipse MGB real-time PCR for detection
of nocturnally periodic Brugia malayi in daytime
blood samples from Indonesia
No. of mf/mla







1–10 3 0 0
11–50 11 0 5 (45)
	50 17 0 12 (71)
a The mf density was estimated by membrane filtration of 1 ml of venous
blood. Night blood was collected between 7 p.m. and 11 p.m. Day blood was
collected between 9 a.m. and noon.
b A total of 200 l of liquid blood was used for the DNA extractions.
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samples (P  0.05), the difference was not as high as ex-
pected from the mf densities. Day and night blood samples
were tested in the same real-time PCR run and normalized
because the DNA of the day blood samples was extracted
from twice as much blood.
DISCUSSION
We developed and evaluated two sensitive real-time PCR
methods for detecting Brugia DNA in blood samples. By
using blood samples from microfilaremic individuals from
Indonesia, we found that the detection of the HhaI repeat
by real-time PCR can be as sensitive as the microscopic
detection of mf, but with a much smaller amount of blood.
The Eclipse MGB real-time PCR assay was more sensitive
than the C-PCR or the TaqM assay, and it detected the
DNA of nocturnally periodic B. malayi in day blood samples.
This represents a significant improvement over previously
available diagnostic methods.
The tandemly repeated 320-bp HhaI sequence of Brugia has
been used as a target for PCR assays for many years (18). The
present study shows that this sequence is also a useful target
for real-time PCR. Early studies estimated that there were
about 30,000 copies of the HhaI repeat per haploid genome of
B. malayi (
10% of the total DNA) (20). Shotgun sequencing
of the B. malayi genome has shown that the HhaI repeat is less
abundant than this and suggests that the HhaI repeat com-
prises only 
1% of the haploid genome (7).
Conventional PCR assays by using the HhaI repeat as a target
can detect
1 pg of B. malayi DNA, which is less than 1% of the
DNA in one mf (18). The combination of C-PCR with ELISA or
test strip detection of amplicons can detect 75 to 500 fg of DNA
(5, 6). The TaqM real-time PCR that we developed also has a
sensitivity in this range (detection limit, 
100 fg).
FIG. 2. Sensitivity of real-time PCR for detection of the HhaI sequence in blood samples. The numbers of copies of the HhaI repeat were
calculated by using external standard curves. Copy numbers were plotted against blood microfilaria counts (mf/ml) on a double logarithmic scale.
(A) TaqM assay results for Brugia malayi blood samples from Sulawesi (R  0.767; P  0.05); (B) TaqM assay results for Brugia timori blood
samples from Alor Island (correlation not significant); (C) Eclipse MGB assay results for B. malayi blood samples from Sulawesi (R  0.42; P 
0.05); (D) Eclipse MGB assay results for B. timori blood samples from Alor Island (correlation not significant).
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The Eclipse MGB real-time PCR assay has a better sensi-
tivity than the other PCR assays tested, with a detection limit
of 0.1 fg, or approximately 22 HhaI copies. It is difficult to
estimate the total copy number of the HhaI repeat in the
Brugia genome on the basis of our data, because not all copies
of the repeat sequence are identical and only a subset may be
detected by the MGB assay. On the basis of the HhaI se-
quences for B. malayi and B. timori available in the public
databases, we estimate that 
70% of the HhaI sequences
should be detected by the MGB assay. If we divide 1.9% (the
estimated percentage of total genomic B. malayi DNA that
comprises HhaI repeat sequences detected by the MGB assay)
by 70% (the percentage of all HhaI sequences detected by the
MGB assay), we estimate that HhaI repeat sequences account
for 2.7% of the B. malayi genome. The haploid genome size of
Brugia is about 90 Mb (7). Thus, the target sequence detected
by the MGB assay comprises 
1.71 Mb, or 5,300 copies per
haploid genome. If a single Brugia cell is present in 100 l
blood, extracted with 50% efficiency, and eluted in 100 l, the
result would be 53 copies of the HhaI target sequence per l of
DNA template (the amount used in one real-time PCR). This
is more than twice as much as our measured detection limit of
22 copies for the MGB assay.
Our field studies used membrane filtration of 1 ml blood
with microscopy as the gold standard for evaluation of PCR
assays. A disadvantage of filtration is that it requires the col-
lection of venous blood by specially trained personnel and
expensive supplies (filters, syringes, etc.). Therefore, the
Global Program to Eliminate Lymphatic Filariasis recom-
mends the use of thick blood smears for assessment of the
prevalence and density of mf in populations (32). Although mf
densities are higher in capillary blood than in venous blood,
membrane filtration of venous blood is more sensitive than the
use of thick smears for the detection of mf because of the large
amount of blood tested by the filter method (1 ml versus 20 to
60 l tested in thick smears) (13). All three PCR assays tested
had sensitivities similar to the sensitivity of membrane filtra-
tion with blood samples from untreated patients in an area
with moderate to high mf densities (Sulawesi). All of these
tests are likely to be much more sensitive than the thick blood
smear method. The increased sensitivity of the Eclipse MGB
real-time assay would be especially important in areas with low
mf densities following MDA (such as Alor Island).
The Eclipse MGB assay had a fairly good sensitivity for the
detection of Brugia DNA in day blood samples from Sulawesi.
Filariasis experts have requested the development of tests that
can replace night blood examination for the detection of mf
(31). The Eclipse MGB assay represents an important step
toward this goal.
Real-time PCR provides an automated and objective means
of detection of specific PCR products and is superior to other
methods, such as agarose gel electrophoresis and Southern
blotting. It also has significant advantages over previous meth-
ods that used a semiautomated quantitative PCR system or
detection of PCR products by ELISA (5, 24). Our group has
recently shown that real-time PCR is superior to C-PCR for
detecting W. bancrofti DNA in blood and mosquito samples
(23). The results from the present study, especially those ob-
tained with the Eclipse MGB assay, confirm that real-time
PCR is superior to C-PCR for the diagnosis of filariasis.
Although brugian filariasis is not common among travelers,
the real-time PCR assay described here (together with similar
assays for other helminth parasites) may be useful for the
diagnosis of filariasis and other helminth infections in travelers
and immigrants with eosinophilia or symptoms consistent with
helminth infections. Since cases of brugian filariasis are rare in
the United States, Europe, and other areas of nonendemicity,
experience with the morphological identification of mf is lim-
ited in these areas and the establishment of an accurate diag-
nosis is often a problem. The assays described here should
permit clinical or reference laboratories without specific exper-
tise in medical helminthology to accurately detect B. malayi or
B. timori in blood samples or biopsy specimens.
While the real-time PCR can be used to diagnose filariasis in
individuals, the main practical importance of these assays will
be as tools for the Global Program to Eliminate Lymphatic
Filariasis. Real-time PCR can be used to screen mosquitoes or
human blood samples to identify and map areas of endemicity.
The assay should also be useful for assessing changes in trans-
mission following MDA by molecular xenomonitoring (29).
One problem with introducing more sensitive diagnostic assays
during the course of ongoing control programs is the compa-
rabilities of different tests. Real-time PCR may detect persis-
tent infections or remnants of parasites that were not detect-
able by traditional methods, such as the thick smear method
(human blood) or dissection (mosquitoes).
PCR assays have significant advantages over other methods
used for the diagnosis of filariasis (greater sensitivity, lower
labor requirements, and high-throughput capability). Since
there is no post-PCR handling of the amplification products,
real-time PCR assays are less prone to contamination than
C-PCR assays that look at PCR products by agarose gel elec-
trophoresis. Although real-time PCR instruments cost more
than conventional thermocyclers, their prices are decreasing
rapidly. Apart from the instrument, the materials costs per
sample for C-PCR and real-time PCR are comparable; labor
costs favor real-time assays, because they do not require a
separate assay for the detection of PCR products. We estimate
that the TaqM assay costs about $3.80 for supplies per sample,
including blood collection, while the Eclipse MGB real-time
assay costs about $4.40 per sample. The higher sensitivity and
applicability for the diagnosis of filariasis with day blood
make the Eclipse test the more promising diagnostic tool.
For comparison, the supply costs for filtration of 1 ml blood,
including venous blood collection, costs about $3.00 per
sample. For large population surveys, the costs of PCR can
be reduced by testing pooled blood samples (26). The
Eclipse MGB real-time assay is slightly more expensive than
the TaqM assay, but its higher sensitivity and applicability
for diagnosis by the use of day blood make it the more
promising diagnostic tool.
In conclusion, our studies have shown that real-time PCR
can be used as a sensitive and specific means of detecting
Brugia DNA in human blood samples. This technology can be
used for the diagnosis of filariasis in individual patients, but it
is likely to be more useful as a tool for the mapping and
monitoring of brugian filariasis in the framework of the Global
Program to Eliminate Lymphatic Filariasis.
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